Cargando…

2108. Comparison of Voriconazole vs. Itraconazole in the Treatment of Histoplasmosis – A Retrospective Analysis

BACKGROUND: The guideline-preferred azole for histoplasmosis (HP) is itraconazole (IC). While voriconazole (VC) has shown success in in-vitro and in retrospective analyses, there has not been enough data to include newer generation azoles as first-line treatment for infections with Histoplasma capsu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hendrix, Michael J, Larson, Lindsey, Rutjanawech, Sasinuch, Franklin, Alexander, Spec, Andrej
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809487/ http://dx.doi.org/10.1093/ofid/ofz360.1788

Ejemplares similares

1085. Epidemiology and Outcomes of Histoplasmosis in Transplant Recipients
por: Rutjanawech, Sasinuch, et al.
Publicado: (2020)

1699. Presentations and Outcomes of Histoplasma capsulatum Infection Vary by Immune Status: A Retrospective Cohort Study
por: Franklin, Alexander, et al.
Publicado: (2019)

923. Long-term Mortality after Histoplasma Infection in People Living with HIV
por: Cherabie, Joseph, et al.
Publicado: (2020)

A Canker Barking at the Wrong Knee: Thyronectria austroamericana Septic Arthritis
por: Rutjanawech, Sasinuch, et al.
Publicado: (2021)

Long-Term Mortality after Histoplasma Infection in People with HIV
por: Cherabie, Joseph, et al.
Publicado: (2021)

120. An open-label comparative trial of SUBA-itraconazole (SUBA) versus conventional itraconazole (c-itra) for treatment of proven and probable endemic mycoses (MSG-15): a pharmacokinetic (PK) and adverse Event (AE) analysis
por: Pappas, Peter G, et al.
Publicado: (2021)

2108. Perfluorocarbon Omniphobic Treatment Prevents Bacterial Colonization of Urinary Catheter in a Rat Model
por: Badv, Maryam, et al.
Publicado: (2018)

Microsporidial Stromal Keratitis: Successful Treatment with Topical Voriconazole and Oral Itraconazole
por: Coca, Mircea, et al.
Publicado: (2016)

COLLABORATION AGREEMENT KE2108/EN
por: THE EUROPEAN ORGANIZATION FOR NUCLEAR RESEARCH, CERN, et al.
Publicado: (2013)

Hepatotoxicity in Advanced Lung Adenocarcinoma: A Retrospective Study of 2108 Cases
por: Qian, Jie, et al.
Publicado: (2018)

2108. In-vitro Activity of Five Novel Anti-Fungal Compounds Against Thirty-Two Strains of Talaromyces marneffei
por: Barwatt, Joseph, et al.
Publicado: (2023)

The Effect of Posaconazole, Itraconazole and Voriconazole in the Culture Medium on Aspergillus fumigatus Triazole Resistance
por: Mroczyńska, Martyna, et al.
Publicado: (2020)

144. MSG-15: Pharmacokinetic (PK), Adverse Events (AEs), and Tolerability Data from an Open Label Randomized Clinical Trial (RCT) Comparing Oral Suba-itraconazole (SUBA-ITC) to Conventional Itraconazole (C-ITC) for Treatment of Endemic Mycosis (EM)
por: Pappas, Peter G, et al.
Publicado: (2020)

2731. Posa-bly the Better Option? Comparison of Posaconazole vs. Itraconazole for Antifungal Prophylaxis After Heart Transplantation
por: Drucker, Darra, et al.
Publicado: (2023)

Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation
por: Marks, David I, et al.
Publicado: (2011)

The Pharmacokinetic Effect of Itraconazole and Voriconazole on Ripretinib in Beagle Dogs by UPLC-MS/MS Technique
por: Wang, Hui-jun, et al.
Publicado: (2021)

Evaluation of fluconazole, itraconazole, and voriconazole activity on Candida albicans: A case control study
por: Partha, Agung Dewi Sekar Langit, et al.
Publicado: (2022)

Effects of the CYP3A inhibitors, voriconazole, itraconazole, and fluconazole on the pharmacokinetics of osimertinib in rats
por: Lou, Yutao, et al.
Publicado: (2023)

Incidence and Risk Factors for colonization of Multidrug-Resistance Organisms (MDROs) among Patients Undergoing Elective Orthopedic Surgery at Thammasat University Hospital
por: Umpunthongsiri, Sirikwan, et al.
Publicado: (2017)

Infectious Disease Prevention and Control: Remembering 1908 and Imagining 2108
por: Brunham, Robert C.
Publicado: (2009)

Comparison of itraconazole, voriconazole, and posaconazole as oral antifungal prophylaxis in pediatric patients following allogeneic hematopoietic stem cell transplantation
por: Döring, M., et al.
Publicado: (2013)

Tolerability of oral itraconazole and voriconazole for the treatment of chronic pulmonary aspergillosis: A systematic review and meta-analysis
por: Olum, Ronald, et al.
Publicado: (2020)

The Pharmacokinetic Effect of Itraconazole and Voriconazole on Ripretinib in Beagle Dogs by UPLC-MS/MS Technique [Corrigendum]
Publicado: (2023)

475. Does Metabolite Matter? Defining Target Itraconazole and Hydroxy-itraconazole Serum Levels for Blastomycosis
por: Hess, Danielle, et al.
Publicado: (2022)

Management of Histoplasmosis by Infectious Disease Physicians
por: Mazi, Patrick B, et al.
Publicado: (2022)

Itraconazole, Voriconazole, and Posaconazole CLSI MIC Distributions for Wild-Type and Azole-Resistant Aspergillus fumigatus Isolates
por: Buil, Jochem B., et al.
Publicado: (2018)

834. A Single-center Experience of Cardiovascular Histoplasmosis: An Emerging Complication of Histoplasmosis
por: Ordaya, Eloy E, et al.
Publicado: (2023)

A Case of Histoplasmosis with Central Nervous System Relapse after Itraconazole Therapy Needs Further Research
por: Peddi, Prashanth, et al.
Publicado: (2020)

168. Creation and Internal Validation of a Clinical Predictive Model for Fluconazole Resistance in Patients with Candida Bloodstream Infection
por: Rauseo, Adriana M, et al.
Publicado: (2020)

271. Fungal Diagnostic Studies in Histoplasmosis
por: Krishnan, Gayathri, et al.
Publicado: (2019)

Hope on the Horizon: Novel Fungal Treatments in Development
por: Rauseo, Adriana M, et al.
Publicado: (2020)

Disseminated histoplasmosis in a cat rescued in Fortaleza, Brazil, and successfully treated with itraconazole – First case report identified molecularly
por: Lomônaco, Liliane Lima da Silva, et al.
Publicado: (2020)

358. Comparison of Voriconazole (VORI), Isavuconazole (ISAV), and Posaconazole (POSA) in the Initial Treatment of Patients With Invasive Aspergillosis (IA)
por: Cheng, Matthew P, et al.
Publicado: (2018)

In vitro susceptibility to amphotericin B, itraconazole, voriconazole, posaconazole and caspofungin of Aspergillus spp. isolated from patients with haematological malignancies in Tunisia
por: Gheith, Soukeina, et al.
Publicado: (2014)

Presentation and Outcome of Cryptococcal Infection Varies by Predisposing Illness
por: Raval, Krunal, et al.
Publicado: (2017)

Itraconazole IV solution in the treatment of candidemia in non-neutropenic patients
por: Tuil, O, et al.
Publicado: (2003)

Comparison between Itraconazole and Cotrimoxazole in the Treatment of Paracoccidiodomycosis
por: Cavalcante, Ricardo de Souza, et al.
Publicado: (2014)

1129. Targeted Voriconazole Prophylaxis in Heart Transplantation Recipients
por: Lin, Michael, et al.
Publicado: (2018)

Pharmacokinetic and clinical comparison of super-bioavailable itraconazole and conventional itraconazole at different dosing in dermatophytosis
por: Dhoot, Dhiraj, et al.
Publicado: (2023)

Efficacy of Environmental Cleaning Protocol Featuring Real-Time Feedback with and without PX-UV in Reducing the Contamination of Gram-Negative Microorganisms on High-Touch Surfaces in Four Intensive Care Units in Thailand
por: Sathitakorn, Ornnicha, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gpjpeqft42ik27i2crlab0l55c